Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siegfried Holding AGXSWX:SFZN +2.25%88 EV-to-OCF is 14.84 as of Aug. 09, 2026, which is 31% below its 10-year median of 21.58. GuruFocus rates XSWX:SFZN with a GF Score™ of 88/100 and a GF Value™ of CHF93.42 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 58.45% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Siegfried Holding AG's Enterprise Value is CHF3,385 Mil.
Siegfried Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF228 Mil. Therefore, Siegfried Holding AG's EV-to-OCF for today is 14.84.
The historical rank and industry rank for Siegfried Holding AG's EV-to-OCF or its related term are showing as below:
XSWX:SFZN'
s EV-to-OCF Range Over the Past 10 Years
Min: 12.58 Med: 21.58 Max: 41.43
Current: 14.84
During the past 13 years, the highest EV-to-OCF of Siegfried Holding AG was 41.43. The lowest was 12.58. And the median was 21.58.
XSWX:SFZN's EV-to-OCF is ranked worse than 58.45% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 11.06
vs XSWX:SFZN: 14.84
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Siegfried Holding AG (XSWX:SFZN) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Siegfried Holding AG's PE Ratio (TTM) for today is calculated as:
Siegfried Holding AG's share price for today is CHF79.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Siegfried Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF3.840.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Siegfried Holding AG EV-to-OCF Related Terms
Siegfried Holding AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SFZN vs ZTS, UTHR, VTRS: EV-to-OCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's EV-to-OCF falls into.
Siegfried Holding AG's current Enterprise Value is CHF3,385 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Siegfried Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF228 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (XSWX:SFZN) has a EV-to-OCF of 14.84 as of Aug. 09, 2026. This is 31% below median its historical median of 21.58. Over the past decade, Siegfried Holding AG's EV-to-OCF has ranged from 12.58 to 41.43. According to the industry distribution chart, Siegfried Holding AG ranks #588 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 58.4%.
Is Siegfried Holding AG's EV-to-OCF too high?
Siegfried Holding AG's current EV-to-OCF of 14.84 is 31% below median its 10-year median of 21.58. Over the past 10 years, this metric has ranged from a low of 12.58 to a high of 41.43. The Drug Manufacturers industry median EV-to-OCF is 11.06. Siegfried Holding AG's value of 14.84 is 34.2% above this industry median. Based on the distribution chart, Siegfried Holding AG ranks #588 out of 1006 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's EV-to-OCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #588 out of 1006 companies for EV-to-OCF. This places Siegfried Holding AG in the lower half of its industry. The industry median EV-to-OCF is 11.06. Siegfried Holding AG's value of 14.84 is 34.2% above this benchmark. Historically, Siegfried Holding AG's own EV-to-OCF has ranged from 12.58 to 41.43 over the past decade. While the company's 10-year median is 21.58 vs. the industry median of 11.06, Siegfried Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 11.06, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current EV-to-OCF of 14.84 is 34.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 11.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current EV-to-OCF is 14.84, which is 31% below median its own 10-year median of 21.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF93.42, compared to a current price of CHF79.65 — trading 14.7% below its estimated fair value. The current EV-to-OCF is 14.84, which is 31% below median its 10-year median of 21.58 and 34.2% above the Drug Manufacturers industry median of 11.06. Siegfried Holding AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current EV-to-OCF is 14.84 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF79.65 is trading 14.7% below its estimated GF Value™ of CHF93.42.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
EV-to-OCF: 14.84 (31% below median its 10-year median of 21.58)
GF Value™: CHF93.42 vs. price of CHF79.65 (14.7% below fair value)
Industry Position: 34.2% above the Drug Manufacturers median (#588 of 1006)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
88GF Score
Get the complete analysis for XSWX:SFZN
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 
